RightAnswer Knowledge Solutions Search Results for 52-67-5

New Search  |  Search Results (52-67-5)  |  Index of Example Chemical Results Pages
register now
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
  • Chemical Identification
  • Environmental Hazards
  • First Aid/Medical Treatment
  • Handling/Storage/Shipping/Waste Management
  • MSDS Documents
  • Personal Protection
  • Physical Hazards/Corrective Response Actions
  • Physical/Chemical Properties
  • Regulatory/Standards/Labels
  • Report Abstracts and Studies
  • Reproductive Risk
  • Toxicology/Health Hazards/Exposure
Example of Acute Exposure data from MEDITEXT.

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documentshelp
MEDITEXT® Documentshelp

All Other Data Sources:

CCRIS Documentshelp
DART Documentshelp
ECOTOX Documentshelp
Fisher MSDShelp
HSDB® Data Bankhelp
LOLI® Listingshelp
REPROTOX® Documentshelp
RTECS® Registryhelp
Shepard's Cataloghelp
TERIS Documentshelp
MSDSonline®help

ChemID External Links:

Other Government Links Searched via RegsKnowledge:

State Environmental Regulationshelp
CFR Regulationshelp

Example Content from MEDITEXT for 52-67-5:


Please note: this is an extract of information from a larger document. Full document and details are available by subscription.

ACUTE EXPOSURE INFORMATION

  1. WITH THERAPEUTIC USE
    1. SIDE EFFECTS - Mild effects include fever, CNS depression, anorexia, nausea, vomiting, loss of taste, abdominal pain, and myalgia.
      1. More serious adverse effects include nephrotic syndrome, hypersensitivity reactions, transient blood dyscrasias, aplastic anemia, neutrophilic agranulocytosis, neutropenia, thrombocytopenia, bronchiolitis obliterans, rashes, dystonia and various autoimmune responses (polymyositis, myasthenia gravis, SLE, Goodpasture's syndrome, thyroiditis).
    1. INCIDENCE of adverse reactions in some studies has been as high as 62%, with 36% experiencing symptoms which necessitated discontinuation of therapy.
    1. DOSE - Most of these toxic side effects occur with chronic administration. The relationship to dose is unclear, as even patients taking small doses may develop toxicity.
    1. FORM - The L isomer and racemic mixture are more toxic than the D isomer.
      1. The N acetylated form of DL-penicillamine has shown less toxicity than the DL mixture itself, and more similar to that of D-penicillamine. This form is still experimental, but has shown some promise.
© 2011-2025 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.